Table 2 -.
Plantar pressure distribution
| Plantar areas | CG | DN | DNU | p | |
|---|---|---|---|---|---|
| Peak pressure (kPa) | Hallux2 | 306.8 (110.7)
36% |
305.6 (111.7)
36% |
269.6 (136.7)
50% |
0.4650 |
| Medial forefoot2 | 347.5 (88.4)
25% |
365.4 (93.7)
25% |
351.6 (92.5)
26% |
0.6912 | |
| Lateral forefoot1 | 328.8 (67.5)
20% |
367.7 (89.2)
24% |
367.2 (86.2)
23% |
0.1096 | |
| Midfoot1 |
139.4 (76.4) 54% |
205.3 (118.6) 57% |
290.7 (151.5) 52% |
0.0008 | |
| Rearfoot1 | 337.4 (95.9)
28% |
342.1 (76.9)
22% |
342.3 (119.1)
34% |
0.7438 | |
| Pressure-time Integral (kPa.s) | Hallux1 | 68.2 (24.5)
36% |
74.3 (26.4)
35% |
60.0 (24.2)
40% |
0.1355 |
| Medial forefoot2 |
97.9 (23.2) 23% |
110.9 (26.5) 23% |
110.0 (31.7)
28% |
0.0403 | |
| Lateral Forefoot2 |
97.7 (18.4) 18% |
119.3 (31.8)
26% |
125.9 (33.4)
26% |
0.0003 | |
| Midfoot1 |
37.3 (11.4) 30% |
43.3 (9.1) 21% |
68.7 (36.5) 53% |
0.0002 | |
| Rearfoot1 |
83.3 (21.2) 25% |
94.9 (29.4) 30% |
102.5 (37.9) 37% |
0.0486 | |
Mean and Standard Deviations (SD) and Coefficient of Variation (%) and p-values. Control Group (CG); Diabetic Neuropathy (DN) and Ulcerated Diabetic Neuropathy (DNU) Groups. Bold data represent the groups that were different from each other.
1
Kruskal Wallis test,
2
ANOVA test.